Get the Stockscreener App
8.14
5.68%
-0.49
After Hours:
8.05
-0.09
-1.11%
Teladoc Health Inc stock is traded at $8.14, with a volume of 10.48M.
It is down -5.68% in the last 24 hours and down -9.66% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$8.63
Open:
$8.51
24h Volume:
10.48M
Relative Volume:
1.44
Market Cap:
$1.44B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-6.8403
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-9.66%
1M Performance:
-9.66%
6M Performance:
+15.30%
1Y Performance:
-11.62%
1-Day Range:
$7.79
$8.51
1-Week Range:
$7.79
$9.15
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.14 | 1.53B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
292.72 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
88.71 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.95 | 12.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.81 | 8.15B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.03 | 6.86B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Will Teladoc Health Inc. (4LL) stock outperform small cap peersWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Is This Beaten-Down Stock Finally on the Road to Recovery? - AOL.com
Is This Beaten-Down Stock Finally on the Road to Recovery? - The Motley Fool
Teladoc Stock Drops on Slowing Growth Forecasts | Q3 2025 ResultsNews and Statistics - IndexBox
Why Teladoc (TDOC) Shares Are Getting Obliterated Today - TradingView
Lumeris launches Rural Health Transformation Program coalition - Modern Healthcare
Teladoc Health, Inc.'s (NYSE:TDOC) Prospects Need A Boost To Lift Shares - 富途牛牛
How Teladoc Health Inc. stock valuations compare to rivalsProduct Launch & Weekly High Conviction Ideas - newser.com
Will Teladoc Health Inc. stock return to pre crash levels2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
How to integrate Teladoc Health Inc. into portfolio analysis toolsQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
What momentum shifts mean for Teladoc Health Inc.Weekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Collaborative for Healthy Rural America™ (CHRA) Launches to Transform Rural Healthcare Nationwide - The AI Journal
Has Teladoc Health Inc. found a price floorWeekly Profit Report & Fast Gain Stock Tips - newser.com
How to recover losses in Teladoc Health Inc. stockPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
Why Teladoc Health Inc. stock could be next big winnerWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressureEarnings Recap Summary & Entry Point Confirmation Signals - newser.com
Will Teladoc Health Inc. (4LL) stock enhance shareholder valueMarket Sentiment Review & Stock Portfolio Risk Management - newser.com
Telestroke Services Market Hits $1.87 Billion in 2024, Forecast - openPR.com
Will Teladoc Health Inc. stock boost dividends furtherPortfolio Return Report & Real-Time Market Sentiment Alerts - newser.com
How Teladoc Health Inc. stock performs after earningsTrend Reversal & Expert Approved Momentum Ideas - newser.com
How Teladoc Health Inc. (4LL) stock compares with top peersMarket Risk Analysis & Daily Profit Focused Screening - newser.com
Trend analysis for Teladoc Health Inc. this weekTake Profit & Daily Growth Stock Investment Tips - newser.com
Is Teladoc Health Inc. stock a contrarian opportunityAnalyst Upgrade & Daily Profit Focused Stock Screening - newser.com
Should you wait for a breakout in Teladoc Health Inc.July 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Leerink Partnrs Forecasts Weaker Earnings for Teladoc Health - MarketBeat
Is Teladoc Health Inc. stock a buy before earnings resultsJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Can Teladoc Health Inc. (4LL) stock sustain revenue momentumPortfolio Performance Summary & Community Trade Idea Sharing - newser.com
Order flow analysis tools used on Teladoc Health Inc.Quarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Does Teladoc Health's (TDOC) Guidance Shift Reflect a New Strategic Growth Focus? - Yahoo Finance
Custom watchlist performance reports with Teladoc Health Inc.Fed Meeting & Intraday High Probability Alerts - newser.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
8.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):